Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

Summary

Thermo Fisher Scientific and the Michael J. Fox Foundation have announced a collaboration to advance proteomics research for Parkinson's disease through the Parkinson's Progression Markers Initiative (PPMI), creating a large-scale proteomics resource to investigate disease progression and biomarker development.